Form 4: Thermo Fisher Director Acquires Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


Thermo Fisher Scientific Inc. director Keith R. Alexandra acquired stock units under the company's Deferred Compensation Plan for Directors.

Summary

  • Keith R. Alexandra, a Director at Thermo Fisher Scientific Inc., acquired 60.91 phantom stock units on June 27, 2026.
  • These units were credited to his account under the Issuer's Deferred Compensation Plan for Directors.
  • The acquisition was made at a price of $513.03 per unit.
  • The phantom stock units are convertible into Common Stock on a 1-for-1 basis.
  • These shares are distributable upon cessation of director service or a change of control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction related to director compensation rather than a significant strategic or financial event.

Positives

  • Director participation in deferred compensation plans indicates alignment with long-term company performance.
  • The acquisition of stock units suggests continued commitment from leadership.

Risks

  • The value of the acquired stock units is subject to fluctuations in Thermo Fisher Scientific's stock price.
  • Distribution of shares is contingent on specific events like cessation of service or change of control.

Future Outlook

The future outlook for the acquired stock units depends on the performance of Thermo Fisher Scientific's common stock and the occurrence of events such as cessation of director service or a change of control.

Industry Context

StockSavvy.ai notes that director stock unit acquisitions are common within the life sciences and healthcare technology sectors, reflecting a standard practice for aligning executive and director interests with shareholder value.

Related Party Transactions

  • Acquisition of phantom stock units by Director Keith R. Alexandra under the Issuer's Deferred Compensation Plan for Directors.

Stakeholder Impact

  • Shareholders: The transaction reflects standard director compensation practices and does not immediately impact share count or ownership structure, but the value of the units is tied to stock performance.
  • Employees: No direct impact.
  • Management: Aligns director interests with company performance.
  • Creditors: No direct impact.

Next Steps

  • Distribution of shares upon cessation of director service or a change of control.

Key Dates

DateDescription
06/27/2026Earliest transaction date and date of acquisition of phantom stock units.
06/30/2026Date of signature for the filing.

Keywords

Thermo Fisher Scientific, TMO, Form 4, Insider Trading, Stock Units, Deferred Compensation, Director Compensation, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.